
FDA Approves Darzalex Faspro (daratumumab) for High-Risk Smoldering Multiple Myeloma: What It Means and Who It Applies To
FDA approves Darzalex Faspro (daratumumab + hyaluronidase) for high-risk smoldering multiple myeloma; learn about AQUILA evidence, dosage, benefits and risks.


















